Anthony Dyer

Geen lopende functies

54 jaar

Consumer Services

Health Technology

Electronic Technology

Profiel

Anthony Dyer served as Director & Chief Corporate Development Officer at Novacyt SAS from 2021 to 2021.
Prior to that, he was Director at Microgen Bioproducts Ltd. from 2014 to 2021.
He will serve as CFO & Non-Executive Director at Love Hemp Group Plc from 2022 to 2023.
Dyer completed his undergraduate degree at the University of East Anglia.

Eerdere bekende functies van Anthony Dyer

Bedrijven	Functie	Einde
Love Hemp Group Plc Love Hemp Group Plc Financial ConglomeratesFinance Invests in medical cannabis industry	Financieel Directeur/CFO	20-01-2023
NOVACYT	Financieel Directeur/CFO	05-01-2021
Microgen Bioproducts Ltd. Microgen Bioproducts Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and distributes diagnostic products for clinical, food, industrial veterinary and environmental testing	Directeur/Bestuurslid	01-04-2021

Ervaring van Anthony Dyer in detail bekijken

Opleiding van Anthony Dyer

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Anthony Dyer in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	4
University of East Anglia University of East Anglia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novacyt SAS Novacyt SAS Medical SpecialtiesHealth Technology Designs, develops and markets molecular real-time PCR testing devices and reagents in the areas of infectious diseases	Health Technology
Microgen Bioproducts Ltd. Microgen Bioproducts Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and distributes diagnostic products for clinical, food, industrial veterinary and environmental testing	Electronic Technology
Love Hemp Group Plc Love Hemp Group Plc Financial ConglomeratesFinance Invests in medical cannabis industry	Finance